Clinical trial
Effect of Intravitreal Bevacizumab on Clinically Significant Macular Edema
NCT00370669 · Shahid Beheshti University of Medical Sciences, Other · Unknown status
Key facts
| NCT number | NCT00370669 |
|---|---|
| Title | Effect of Intravitreal Bevacizumab on Clinically Significant Macular Edema |
| Lead sponsor | Shahid Beheshti University of Medical Sciences, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetic Macular Edema |
| Intervention type | Drug |
| Interventions | bevacizumab, triamcinolone acetonide |
| Enrollment | 150 |
| Start date | Nov 1, 2005 |
| Completion | Feb 1, 2007 |
| First posted | Sep 1, 2006 |
| Last update posted | Feb 22, 2007 |
| Countries | Iran |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: